-
公开(公告)号：US07163929B2
公开(公告)日：2007-01-16
申请号：US10602135
申请日：2003-06-20
CPC分类号： A61K31/7072 , A61K31/7052 , A61K31/7056 , A61K31/7064 , A61K31/7076 , A61K38/21 , C07H19/06 , C07H19/073 , C07H19/10 , C07H19/16 , C07H19/20 , C07H19/23 , Y02A50/385 , Y02A50/387 , Y02A50/389
摘要： A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
摘要翻译： 提供用于治疗感染黄病毒或瘟病毒的宿主的方法和组合物，其包括施用有效的黄病毒或瘟病毒处理量的所述1'，2'或3'-修饰的核苷或其药学上可接受的盐或前药。
-
公开(公告)号：US07157441B2
公开(公告)日：2007-01-02
申请号：US10602136
申请日：2003-06-20
CPC分类号： A61K31/708 , A61K31/7056 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K38/21 , A61K45/06 , C07H19/04 , C07H19/06 , C07H19/10 , C07H19/16 , C07H19/20 , G03C1/0051
摘要： A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
-
公开(公告)号：US20050137161A1
公开(公告)日：2005-06-23
申请号：US10602136
申请日：2003-06-20
IPC分类号： C07D473/18 , A61K31/513 , A61K31/52 , A61K31/522 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K31/708 , A61P1/16 , A61P31/12 , A61P31/14 , C07D405/04 , C07D473/30 , C07D473/34 , C07H19/04 , C07H19/06 , C07H19/067 , C07H19/073 , C07H19/10 , C07H19/16 , C07H19/167 , C07H19/173 , C07H19/20
CPC分类号： A61K31/708 , A61K31/7056 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K38/21 , A61K45/06 , C07H19/04 , C07H19/06 , C07H19/10 , C07H19/16 , C07H19/20 , G03C1/0051
摘要： A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
摘要翻译： 提供用于治疗感染丙型肝炎的宿主的方法和组合物，其包括施用有效的丙型肝炎治疗量的所述1'，2'或3'-修饰的核苷或其药学上可接受的盐或前药。
-
公开(公告)号：US07169766B2
公开(公告)日：2007-01-30
申请号：US10602976
申请日：2003-06-20
CPC分类号： A61K31/708 , A61K31/7056 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K38/21 , A61K45/06 , C07H19/04 , C07H19/06 , C07H19/10 , C07H19/16 , C07H19/20 , G03C1/0051
摘要： A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
摘要翻译： 提供用于治疗感染丙型肝炎的宿主的方法和组合物，其包括施用有效的丙型肝炎治疗量的所述1'，2'或3'-修饰的核苷或其药学上可接受的盐或前药。
-
公开(公告)号：US07101861B2
公开(公告)日：2006-09-05
申请号：US10602692
申请日：2003-06-20
CPC分类号： A61K31/7072 , A61K31/7052 , A61K31/7056 , A61K31/7064 , A61K31/7076 , A61K38/21 , C07H19/06 , C07H19/073 , C07H19/10 , C07H19/16 , C07H19/20 , C07H19/23 , Y02A50/385 , Y02A50/387 , Y02A50/389
摘要： A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
-
公开(公告)号：US20060166865A1
公开(公告)日：2006-07-27
申请号：US10602135
申请日：2003-06-20
IPC分类号： A61K38/16 , A61K31/7076 , A61K31/675 , A61K31/655 , A61K31/519
CPC分类号： A61K31/7072 , A61K31/7052 , A61K31/7056 , A61K31/7064 , A61K31/7076 , A61K38/21 , C07H19/06 , C07H19/073 , C07H19/10 , C07H19/16 , C07H19/20 , C07H19/23 , Y02A50/385 , Y02A50/387 , Y02A50/389
摘要： A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
-
公开(公告)号：US08343937B2
公开(公告)日：2013-01-01
申请号：US11527124
申请日：2006-09-25
CPC分类号： A61K31/7072 , A61K31/7052 , A61K31/7056 , A61K31/7064 , A61K31/7076 , A61K38/21 , C07H19/06 , C07H19/073 , C07H19/10 , C07H19/16 , C07H19/20 , C07H19/23 , Y02A50/385 , Y02A50/387 , Y02A50/389
摘要： A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
摘要翻译： 提供用于治疗感染黄病毒或瘟病毒的宿主的方法和组合物，其包括施用有效的黄病毒或瘟病毒处理量的所述1'，2'或3'-修饰的核苷或其药学上可接受的盐或前药。
-
公开(公告)号：US20090280086A1
公开(公告)日：2009-11-12
申请号：US12504601
申请日：2009-07-16
IPC分类号： A61K38/21 , A61K31/7076 , A61K31/7068 , C07H19/167 , A61P31/12
CPC分类号： A61K31/708 , A61K31/7056 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K38/21 , A61K45/06 , C07H19/04 , C07H19/06 , C07H19/10 , C07H19/16 , C07H19/20 , G03C1/0051
摘要： A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
摘要翻译： 提供用于治疗感染丙型肝炎的宿主的方法和组合物，其包括施用有效的丙型肝炎治疗量的所述1'，2'或3'-修饰的核苷或其药学上可接受的盐或前药。
-
公开(公告)号：US20070037773A1
公开(公告)日：2007-02-15
申请号：US11527124
申请日：2006-09-25
IPC分类号： A61K31/7076 , C07H19/16 , C07H19/19
CPC分类号： A61K31/7072 , A61K31/7052 , A61K31/7056 , A61K31/7064 , A61K31/7076 , A61K38/21 , C07H19/06 , C07H19/073 , C07H19/10 , C07H19/16 , C07H19/20 , C07H19/23 , Y02A50/385 , Y02A50/387 , Y02A50/389
摘要： A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
-
公开(公告)号：US08299038B2
公开(公告)日：2012-10-30
申请号：US12504601
申请日：2009-07-16
CPC分类号： A61K31/708 , A61K31/7056 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K38/21 , A61K45/06 , C07H19/04 , C07H19/06 , C07H19/10 , C07H19/16 , C07H19/20 , G03C1/0051
摘要： A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
摘要翻译： 提供用于治疗感染丙型肝炎的宿主的方法和组合物，其包括施用有效的丙型肝炎治疗量的所述1'，2'或3'-修饰的核苷或其药学上可接受的盐或前药。
-
-
-
-
-
-
-
-
-
搜索结果
86 条记录 (耗时 0.038 秒)
